Infirmary Health Performs First-On-The-Gulf AFib Procedure

Infirmary Health’s Heart & Vascular Institute is now providing advanced treatment for atrial fibrillation (AFib) with the Optrell Mapping Catheter with TRUEref Technology from Biosense Webster. Dr. Andin Mullis, a cardiac electrophysiologist, performed the first Optrell catheter procedure across the Gulf Coast Region at Mobile Infirmary. This technology delivers high-resolution directional mapping of arrhythmias in any chamber, guiding the physician to quickly and effectively identify ablation targets. AFib is the most common type of cardiac arrhythmia, or abnormal heart rhythm, affecting more than 40 million people worldwide. A catheter ablation is a safe and effective treatment method for patients with AFib. During an ablation, the heart’s incorrect electrical signals are restored. A catheter ablation, typically performed by an electrophysiologist, can provide a patient with improved quality of life, symptom relief and elimination of long-term risk of stroke and heart attack.

Read More

Mathews To Headline First Regions Arena Event

Mathews To Headline First Regions Arena Event

Moore Coming To Saenger

Moore Coming To Saenger

Buffett Exhibit To Open September 12

Buffett Exhibit To Open September 12

ADCNR Awarded $7.1 Million To Improve Oyster Resilience

ADCNR Awarded $7.1 Million To Improve Oyster Resilience

ADCNR Hunter Education Classes Coming Up

ADCNR Hunter Education Classes Coming Up

Grants Accepted For Little Dauphin Island Restoration

Grants Accepted For Little Dauphin Island Restoration

Mobile Bay Inspiration Home Tours Continue Through August 30

Mobile Bay Inspiration Home Tours Continue Through August 30

Wilkins Miller Named A Top Accounting Firm To Work For

Wilkins Miller Named A Top Accounting Firm To Work For

Keesler Federal Battleship 12k To Be Held In November

Keesler Federal Battleship 12k To Be Held In November

Subscribe to our weekly newsletter

Sign up here for free to get Bay Business News email newsletter every Friday.

By subscribing, you agree to our User Agreement and Privacy Policy & Cookie Statement.

Something went wrong. Please check your entries and try again.